Skip to main content
. 2022 Aug 23;13:954235. doi: 10.3389/fimmu.2022.954235

Figure 4.

Figure 4

Two combinations of CD19 and CD22 CAR T cell products as an example of combinations among different types of CAR T cells. (A) Cocktail infusion of CD19 and CD22 CAR T cells for addressing antigen-negative relapse. (B) Sequential infusion of CD19 and CD22 CAR T cells according to the in vivo activity of CAR T cells and patient status to overcome both short duration and antigen escape.